NLRP3 and neoplasm: The OT1-mediated killing of target tumour cells in vivo induced IL-1β production through antigen presentation and NLRP3 inflammasome, indicating that the OVA tumour antigen was presented by APCs to activate OT1 T cells, and the CTLs then activated NLRP3 inflammasome in APCs.